According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

After more than a half-decade, dozens of government hearings and votes, a name change, an ownership change and a special election, the sprawling Redtail Ridge mega-development in Louisville is ...

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...

Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines. Here's what investors need to know about this small-cap biotech company. Iovance ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

TC Biopharm shares are trading lower by 64% during Friday's session. The company announced the transition from Nasdaq to OTC ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Here’s what happened after RFK Jr. paused Peninsula company's half-billion-dollar vaccine contract. Spoiler alert: It wasn’t ...

Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...